参考文献
1.CAMERON D，JONES IG.John Snow，the Broad Street Pump and Modern Epidemiology.Int.J.Epidemiol.1983；12：393-396.
2.Stolberg HO，Norman G，Trop I.Randomized controlled trials.AJR.Am.J.Roentgenol. 2004；183：1539-44.
3.DOLL R，HILL AB.Smoking and carcinoma of the lung；preliminary report.Br.Med.J. 1950；2：739-48.
4.Doll R，Hill AB.The Mortality of Doctors in Relation to Their Smoking Habits.BMJ.1954；1：1451-1455.
5.DAWBER TR，KANNEL WB.Computers in epidemiologic research.Uses in the Framingham study.Circ.Res.1962；11：587-9.
6.KANNEL WB，DAWBER TR，KAGAN A，REVOTSKIE N，STOKES J.Factors of risk in the development of coronary heart disease--six year follow-up experience.The Framingham Study.Ann.Intern.Med.1961；55：33-50.
7.Wilson PW，D'Agostino RB，Levy D，Belanger AM，Silbershatz H，Kannel WB.Prediction of coronary heart disease using risk factor categories.Circulation.1998；97：1837-47.
8.Belanger CF，Hennekens CH，Rosner B，Speizer FE.The nurses'health study.Am.J.Nurs. 1978；78：1039-40.
9.Riboli E，Hunt KJ，Slimani N，Ferrari P，Norat T，Fahey M，Charrondière UR，Hémon B，Casagrande C，Vignat J，Overvad K，Tjønneland A，Clavel-Chapelon F，Thiébaut A，Wahrendorf J，Boeing H，Trichopoulos D，Trichopoulou A，Vineis P，Palli D，Bueno-De-Mesquita HB，Peeters PHM，Lund E，Engeset D，González CA，Barricarte A，Berglund G，Hallmans G，Day NE，Key TJ，Kaaks R，Saracci R.European Prospective Investigation into Cancer and Nutrition（EPIC）：study populations and data collection.PublicHealthNutr.2002；5：1113-24.
10.P3 G.Study Catalogue Statistics［Internet］.P3 G Obs.-Stat.2014；
11.Manolio TA，Bailey-Wilson JE，Collins FS.Genes，environment and the value of prospective cohort studies.Nat.Rev.Genet.2006；7：812-20.
12.Hunter DJ.Gene-environment interactions in human diseases.Nat.Rev.Genet.2005；6：287-98.
13.Collins FS.The case for a US prospective cohort study of genes and environment.Nature.2004；429：475-7.
14.Gauderman WJ.Sample size requirements for matched case-control studies of gene-environment interaction.Stat.Med.2002；21：35-50.
15.Hildebrandt M.Slaves to Big Data.Or Are We？［Internet］.IDP.Rev.INTERNET，DERECHO Y POLÍTICA 16.2013；
16.Mayer-Schönberger V，Cukier K.Big Data：A Revolution that Will Transform how We Live，Work，and Think［Internet］.Houghton Mifflin Harcourt；2013.
17.Cook S，Conrad C，Fowlkes AL，Mohebbi MH.Assessing Google flu trends performance in the United States during the 2009influenza virus A（H1N1）pandemic.PLoSOne.2011；6：e23610.
18.Butler D.When Google got flu wrong.Nature.2013；494：155-6.
19.Data B，Zhou M，States U，Grimmer J，King G，Science QS.The Age of Big Data.New York Times.2012；：1-5.
20.Lynch C.Big data：How do your data grow？Nature.2008；455：28-9.
21.Wild CP，Scalbert A，Herceg Z.Measuring the exposome：apowerful basis for evaluating environmental exposures and cancer risk.Environ.Mol.Mutagen.2013；54：480-99.
22.White E，Hunt JR，Casso D.Exposure measurement in cohort studies：the challenges of prospective data collection.Epidemiol.Rev.1998；20：43-56.
23.Kondo N.Socioeconomic disparities and health：impacts and pathways.J.Epidemiol. 2012；22：2-6.
24.Mahabir S.Association between diet during preadolescence and adolescence and risk for breast cancer during adulthood.J.Adolesc.Health.2013；52：S30-5.
25.Boffetta P，Fryzek JP，Mandel JS.Occupational exposure to beryllium and cancer risk：a review of the epidemiologic evidence.Crit.Rev.Toxicol.2012；42：107-18.
26.Boffetta P.A review of cancer risk in the trucking industry，with emphasis on exposure to diesel exhaust.G.Ital.Med.Lav.Ergon.34：365-70.
27.Nicholson JK，Wilson ID，Lindon JC.Pharmacometabonomics as an effector for personalized medicine.Pharmacogenomics.2011；12：103-11.
28.Evrard A，Mbatchi L.Genetic polymorphisms of drug metabolizing enzymes and transporters：the long way from bench to bedside.Curr.Top.Med.Chem.2012；12：1720-9.
29.Arakawa K，Tomita M.Merging multiple omics datasets in silico：statistical analyses and data interpretation.Methods Mol.Biol.2013；985：459-70.
30.Forrest MS，Lan Q，Hubbard AE，Zhang L，Vermeulen R，Zhao X，Li G，Wu Y-Y，Shen M，Yin S，Chanock SJ，Rothman N，Smith MT.Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers.Environ.Health Perspect.2005；113：801-7.
31.Fry RC，Navasumrit P，Valiathan C，Svensson JP，Hogan BJ，Luo M，Bhattacharya S，Kandjanapa K，Soontararuks S，Nookabkaew S，Mahidol C，Ruchirawat M，Samson LD.Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers.PLoS Genet.2007；3：e207.
32.Spira A，Beane J，Shah V，Liu G，Schembri F，Yang X，Palma J，Brody JS.Effects of cigarette smoke on the human airway epithelial cell transcriptome.Proc.Natl.Acad.Sci.U.S.A. 2004；101：10143-8.
33.Wan ES，Qiu W，Baccarelli A，Carey VJ，Bacherman H，Rennard SI，Agusti A，Anderson W，Lomas DA，Demeo DL.Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome.Hum.Mol.Genet. 2012；21：3073-82.
34.Joubert BR，Håberg SE，Nilsen RM，Wang X，Vollset SE，Murphy SK，Huang Z，Hoyo C，MidttunØ，Cupul-Uicab LA，Ueland PM，Wu MC，Nystad W，Bell DA，Peddada SD，London SJ.450Kepigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy.Environ.Health Perspect.2012；120：1425-31.
35.Van Dorsten FA，Daykin CA，Mulder TPJ，Van Duynhoven JPM.Metabonomics approach to determine metabolic differences between green tea and black tea consumption.J.Agric.FoodChem.2006；54：6929-38.
36.Llorach R，Urpi-Sarda M，Jauregui O，Monagas M，Andres-Lacueva C.An LC-MS-based metabolomics approach for exploring urinary metabolome modifications after cocoa consumption.J.Proteome Res.2009；8：5060-8.
37.Würtz P，Mäkinen V-P，Soininen P，Kangas AJ，Tukiainen T，Kettunen J，Savolainen MJ，Tammelin T，Viikari JS，Rönnemaa T，Kähönen M，Lehtimäki T，Ripatti S，Raitakari OT，Järvelin M-R，Ala-Korpela M.Metabolic signatures of insulin resistance in 7，098young adults.Diabetes.2012；61：1372-80.
38.Wang K-C，Kuo C-H，Tian T-F，Tsai M-H，Chiung Y-M，Hsiech C-M，Tsai S-J，Wang S-Y，Tsai D-M，Huang C-C，Tseng YJ.Metabolomic characterization of laborers exposed to welding fumes.Chem.Res.Toxicol.2012；25：676-86.
39.Pleil JD，Stiegel MA，Sobus JR.Breath biomarkers in environmental health science：exploring patterns in the human exposome.J.Breath Res.2011；5：046005.
40.Wang-Sattler R，Yu Y，Mittelstrass K，Lattka E，Altmaier E，Gieger C，Ladwig KH，Dahmen N，Weinberger KM，Hao P，Liu L，Li Y，Wichmann H-E，Adamski J，Suhre K，Illig T.Metabolic profiling reveals distinct variations linked to nicotine consumption in humans--first results from the KORA study.PLoS One.2008；3：e3863.
41.Pechlivanis A，Kostidis S，Saraslanidis P，Petridou A，Tsalis G，Mougios V，Gika HG，Mikros E，Theodoridis GA.（1）H NMR-based metabonomic investigation of the effect of two different exercise sessions on the metabolic fingerprint of human urine. J.Proteome Res.2010；9：6405-16.
42.Lehmann R，Zhao X，Weigert C，Simon P，Fehrenbach E，Fritsche J，Machann J，Schick F，Wang J，Hoene M，Schleicher ED，Häring H-U，Xu G，Niess AM.Medium chain acylcarnitines dominate the metabolite pattern in humans under moderate intensity exercise and support lipid oxidation.PLoS One.2010；5：e11519.
43.Oberbach A，Blüher M，Wirth H，Till H，Kovacs P，Kullnick Y，Schlichting N，Tomm JM，Rolle-Kampczyk U，Murugaiyan J，Binder H，Dietrich A，von Bergen M.Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes.J.ProteomeRes.2011；10：4769-88.
44.Keun HC，Sidhu J，Pchejetski D，Lewis JS，Marconell H，Patterson M，Bloom SR，Amber V，Coombes RC，Stebbing J.Serum molecular signatures of weight change during early breast cancer chemotherapy.Clin.Cancer Res.2009；15：6716-23.
45.Huffman KM，Shah SH，Stevens RD，Bain JR，Muehlbauer M，Slentz CA，Tanner CJ，Kuchibhatla M，Houmard JA，Newgard CB，Kraus WE.Relationships between circulating metabolic intermediates and insulin action in overweight to obese，inactive men and women.Diabetes Care.2009；32：1678-83.
46.Wild CP.Complementing the genome with an“exposome”：the outstanding challenge of environmental exposure measurement in molecular epidemiology.Cancer Epidemiol.Biomarkers Prev.2005；14：1847-50.
47.Wild CP.The exposome：from concept to utility.Int.J.Epidemiol.2012；41：24-32.
48.Mayer C-D，Lorent J，Horgan GW.Exploratory analysis of multiple omics datasets using the adjusted RV coefficient.Stat.Appl.Genet.Mol.Biol.2011；10：Article 14.
49.Arbogast PG，Ray WA.Performance of disease risk scores，propensity scores，and traditional multivariable outcome regression in the presence of multiple confounders.Am. J.Epidemiol.2011；174：613-20.
50.Manolio TA，Weis BK，Cowie CC，Hoover RN，Hudson K，Kramer BS，Berg C，Collins R，Ewart W，Gaziano JM，Hirschfeld S，Marcus PM，Masys D，McCarty CA，McLaughlin J，Patel A V，Peakman T，Pedersen NL，Schaefer C，Scott JA，Sprosen T，Walport M，Collins FS.New models for large prospective studies：is there a better way？Am.J.Epidemiol.2012；175：859-66.
51.Gottweis H，Lauss G.Biobank governance：heterogeneous modes of ordering and democratization.J.Community Genet.2012；3：61-72.
52.Watts G.Will UK Biobank pay off？BMJ.2006；332：1052.